Literature DB >> 11161284

Measles virus and canine distemper virus target proteins into a TAP-independent MHC class I-restricted antigen-processing pathway.

Claudia Neumeister1, Ralph Nanan2, Tatjana I Cornu3, Carsten G K Lüder4, Volker Ter Meulen1, Hussein Naim3, Stefan Niewiesk1.   

Abstract

After infection of CEM174.T2 cells [deficient for the transporter of antigen presentation (TAP)] with measles virus (MV) the nucleocapsid protein is recognized by L(d)-restricted cytotoxic T cells in a TAP-independent, chloroquine-sensitive fashion. Presentation via the TAP-independent pathway requires virus replication. During MV infection of the cell the nucleocapsid as well as the matrix protein enter the endolysosomal compartment as indicated by colocalization with the lysosomal-associated membrane protein 1 (LAMP-1). Similarly, the nucleocapsid protein of canine distemper virus (CDV) is recognized in a TAP-independent fashion. In addition, a recombinant MV expressing bacterial beta-galactosidase protein is able to introduce the recombinant antigen into the TAP-independent pathway whereas a vaccinia virus expressing beta-galactosidase is not. These data and a report about TAP-independent recognition of parainfluenza virus type 1 suggest that members of the Paramyxoviridae family regularly introduce viral proteins into the TAP-independent antigen-processing pathway.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11161284     DOI: 10.1099/0022-1317-82-2-441

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  8 in total

Review 1.  Generation of MHC class I ligands in the secretory and vesicular pathways.

Authors:  Margarita Del Val; Salvador Iborra; Manuel Ramos; Silvia Lázaro
Journal:  Cell Mol Life Sci       Date:  2011-03-09       Impact factor: 9.261

2.  Allele-dependent processing pathways generate the endogenous human leukocyte antigen (HLA) class I peptide repertoire in transporters associated with antigen processing (TAP)-deficient cells.

Authors:  Elena Lorente; Ruth García; Daniel López
Journal:  J Biol Chem       Date:  2011-09-13       Impact factor: 5.157

3.  Role of metalloproteases in vaccinia virus epitope processing for transporter associated with antigen processing (TAP)-independent human leukocyte antigen (HLA)-B7 class I antigen presentation.

Authors:  Elena Lorente; Ruth García; Carmen Mir; Alejandro Barriga; François A Lemonnier; Manuel Ramos; Daniel López
Journal:  J Biol Chem       Date:  2012-02-01       Impact factor: 5.157

4.  Genetic polymorphisms of LMP/TAP gene and hepatitis B virus infection risk in the Chinese population.

Authors:  Changqing Xu; Suxia Qi; Lei Gao; Hong Cui; Meiqiang Liu; Hongli Yang; Kun Li; Bangwei Cao
Journal:  J Clin Immunol       Date:  2007-05-25       Impact factor: 8.317

5.  Defective ribosomal products are the major source of antigenic peptides endogenously generated from influenza A virus neuraminidase.

Authors:  Brian P Dolan; Lily Li; Kazuyo Takeda; Jack R Bennink; Jonathan W Yewdell
Journal:  J Immunol       Date:  2009-12-28       Impact factor: 5.422

6.  Heterozygote of TAP1 Codon637 decreases susceptibility to HPV infection but increases susceptibility to esophageal cancer among the Kazakh populations.

Authors:  Ningjing Zou; Lan Yang; Ling Chen; Tingting Li; Tingting Jin; Hao Peng; Shumao Zhang; Dandan Wang; Ranran Li; Chunxia Liu; Jinfang Jiang; Lianghai Wang; Weihua Liang; Jianming Hu; Shugang Li; Chuanyue Wu; Xiaobin Cui; Yunzhao Chen; Feng Li
Journal:  J Exp Clin Cancer Res       Date:  2015-07-25

7.  Attenuated measles virus as a vaccine vector.

Authors:  Armando Zuniga; Zili Wang; Matthias Liniger; Lars Hangartner; Michael Caballero; Jovan Pavlovic; Peter Wild; Jean Francois Viret; Reinhard Glueck; Martin A Billeter; Hussein Y Naim
Journal:  Vaccine       Date:  2007-02-02       Impact factor: 3.641

8.  Induction of neutralising antibodies and cellular immune responses against SARS coronavirus by recombinant measles viruses.

Authors:  Matthias Liniger; Armando Zuniga; Azaibi Tamin; Teldja N Azzouz-Morin; Marlyse Knuchel; Rene R Marty; Marian Wiegand; Sara Weibel; David Kelvin; Paul A Rota; Hussein Y Naim
Journal:  Vaccine       Date:  2008-02-22       Impact factor: 3.641

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.